Getein Biotech, Inc (SHA:603387)
China · Delayed Price · Currency is CNY 7.98
-0.08 (-0.99%)
Jun 11, 2026, 3:00 PM CST
Getein Biotech Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 4,047 | 4,245 | 4,184 | 5,579 | 6,339 | 7,254 | |
Market Cap Growth | -1.60% | 1.46% | -25.00% | -12.00% | -12.61% | -18.60% |
Enterprise Value | 3,409 | 3,846 | 3,896 | 5,572 | 5,454 | 6,496 |
Last Close Price | 7.98 | 8.37 | 8.07 | 10.50 | 11.56 | 13.02 |
PE Ratio | 18.14 | 19.24 | 18.71 | 19.94 | 12.71 | 18.18 |
Forward PE | - | 17.43 | 17.43 | 17.43 | 17.43 | 17.43 |
PS Ratio | 3.76 | 4.04 | 3.59 | 4.08 | 3.48 | 5.18 |
PB Ratio | 1.38 | 1.49 | 1.54 | 2.04 | 2.38 | 3.19 |
P/TBV Ratio | 1.53 | 1.65 | 1.69 | 2.31 | 2.70 | 3.62 |
P/FCF Ratio | 14.39 | 17.54 | 15.69 | 74.29 | 23.88 | 28.70 |
P/OCF Ratio | 9.72 | 10.81 | 9.89 | 16.74 | 13.13 | 16.78 |
EV/Sales Ratio | 3.24 | 3.66 | 3.34 | 4.07 | 2.99 | 4.64 |
EV/EBITDA Ratio | 11.64 | 13.22 | 12.65 | 18.72 | 9.71 | 14.21 |
EV/EBIT Ratio | 16.32 | 18.41 | 17.65 | 26.25 | 10.97 | 15.86 |
EV/FCF Ratio | 12.12 | 15.89 | 14.61 | 74.20 | 20.54 | 25.70 |
Debt / Equity Ratio | 0.14 | 0.17 | 0.21 | 0.24 | 0.22 | 0.22 |
Debt / EBITDA Ratio | 1.32 | 1.65 | 1.85 | 2.18 | 1.04 | 1.08 |
Debt / FCF Ratio | 1.43 | 1.99 | 2.18 | 8.88 | 2.23 | 1.96 |
Net Debt / Equity Ratio | -0.33 | -0.26 | -0.15 | -0.10 | -0.21 | -0.48 |
Net Debt / EBITDA Ratio | -3.16 | -2.56 | -1.36 | -0.90 | -1.01 | -2.37 |
Net Debt / FCF Ratio | -3.40 | -3.08 | -1.57 | -3.59 | -2.13 | -4.29 |
Asset Turnover | 0.29 | 0.28 | 0.31 | 0.37 | 0.54 | 0.48 |
Inventory Turnover | 1.83 | 1.80 | 1.83 | 1.92 | 2.58 | 2.09 |
Quick Ratio | 2.37 | 1.94 | 1.50 | 1.56 | 1.77 | 2.54 |
Current Ratio | 3.21 | 2.69 | 1.98 | 2.20 | 2.50 | 2.91 |
Return on Equity (ROE) | 7.81% | 7.60% | 8.42% | 10.51% | 20.41% | 19.26% |
Return on Assets (ROA) | 3.74% | 3.50% | 3.69% | 3.56% | 9.11% | 8.77% |
Return on Invested Capital (ROIC) | 10.03% | 8.80% | 8.39% | 8.65% | 27.21% | 34.26% |
Return on Capital Employed (ROCE) | 7.50% | 7.20% | 8.00% | 7.60% | 18.30% | 17.60% |
Earnings Yield | 5.75% | 5.20% | 5.34% | 5.01% | 7.87% | 5.50% |
FCF Yield | 6.95% | 5.70% | 6.37% | 1.35% | 4.19% | 3.48% |
Dividend Yield | 3.72% | 2.87% | 2.23% | 1.91% | 2.94% | 1.86% |
Payout Ratio | 44.45% | 46.78% | 49.63% | 78.42% | 28.21% | 25.96% |
Buyback Yield / Dilution | 0.09% | 1.33% | 0.08% | 0.08% | 0.48% | -0.72% |
Total Shareholder Return | 3.74% | 4.20% | 2.31% | 1.99% | 3.42% | 1.15% |